BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-9.76%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$16.2B
AUM Growth
+$16.2B
(-14%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
86.32%
Holding
116
New
17
Increased
25
Reduced
19
Closed
6
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$45.1M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$44.4M |
| 3 |
Kodiak Sciences
KOD
|
$25.1M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$22M |
| 5 |
ALLK
Allakos
ALLK
|
$17.6M |
Top Sells
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$48.2M |
| 2 |
Exact Sciences
EXAS
|
$42.9M |
| 3 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$11.4M |
| 4 |
Adaptive Biotechnologies
ADPT
|
$10.3M |
| 5 |
NextCure
NXTC
|
$8.45M |
Sector Composition
| 1 | Healthcare | 98.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.78B | 35.57% | 50,060,240 +2,963 | +0% | +$342K |
|
2
Incyte
INCY
$16.5B
| $2.34B | 14.42% | 31,978,785 +1,912 | +0% | +$140K |
|
|
3
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.77B | 10.9% | 41,904,586 +1,050,000 | +3% | +$44.4M |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.45B | 8.93% | 11,777,285 | – | – |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $787M | 4.84% | 8,760,794 +502,726 | +6% | +$45.1M |
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $641M | 3.95% | 7,589,294 | – | – |
|
|
7
Kodiak Sciences
KOD
$478M
| $552M | 3.4% | 11,574,538 +527,249 | +5% | +$25.1M |
|
8
Ascendis Pharma
ASND
$11.8B
| $382M | 2.35% | 3,390,270 | – | – |
|
|
IGMS
9
DELISTED
IGM Biosciences
IGMS
| $177M | 1.09% | 3,144,000 | – | – |
|
|
AMRN
10
Amarin Corp
AMRN
$311M
| $138M | 0.85% | 34,496,685 | – | – |
|
11
argenx
ARGX
$43.6B
| $134M | 0.83% | 1,019,557 | – | – |
|
|
NVTA
12
DELISTED
Invitae Corporation
NVTA
| $124M | 0.77% | 9,100,615 +3,450 | +0% | +$47.2K |
|
|
PRNB
13
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $116M | 0.72% | 1,955,413 +167,456 | +9% | +$9.94M |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $108M | 0.67% | 1,409,784 +102,564 | +8% | +$7.88M |
|
15
Neurocrine Biosciences
NBIX
$13.8B
| $107M | 0.66% | 1,240,243 -14,000 | -1% | -$1.21M |
|
|
16
Exact Sciences
EXAS
$8.98B
| $107M | 0.66% | 1,846,139 -739,652 | -29% | -$42.9M |
|
|
RARX
17
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $101M | 0.62% | 2,093,839 | – | – |
|
|
18
Madrigal Pharmaceuticals
MDGL
$9.76B
| $100M | 0.62% | 1,499,212 +329,934 | +28% | +$22M |
|
|
MYOK
19
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $83.2M | 0.51% | 1,774,234 | – | – |
|
20
Heron Therapeutics
HRTX
$207M
| $70.7M | 0.44% | 6,018,104 | – | – |
|
21
Cerus
CERS
$251M
| $63.8M | 0.39% | 13,713,195 +2,963,258 | +28% | +$13.8M |
|
22
Zymeworks
ZYME
$1.12B
| $60.6M | 0.37% | 1,708,472 | – | – |
|
|
TCDA
23
DELISTED
Tricida, Inc. Common Stock
TCDA
| $58.7M | 0.36% | 2,666,015 +696,110 | +35% | +$15.3M |
|
|
BCEL
24
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $58.5M | 0.36% | 3,532,760 | – | – |
|
|
DBVT
25
DBV Technologies
DBVT
$264M
| $57.3M | 0.35% | 14,614,264 | – | – |
|